<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1" />

<meta name="author" content="Hugo Pedder" />

<meta name="date" content="2025-01-28" />

<title>Perform a time-course Model-Based Network Meta-Analysis (MBNMA)</title>

<script>// Pandoc 2.9 adds attributes on both header and div. We remove the former (to
// be compatible with the behavior of Pandoc < 2.8).
document.addEventListener('DOMContentLoaded', function(e) {
  var hs = document.querySelectorAll("div.section[class*='level'] > :first-child");
  var i, h, a;
  for (i = 0; i < hs.length; i++) {
    h = hs[i];
    if (!/^h[1-6]$/i.test(h.tagName)) continue;  // it should be a header h1-h6
    a = h.attributes;
    while (a.length > 0) h.removeAttribute(a[0].name);
  }
});
</script>

<style type="text/css">
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
span.underline{text-decoration: underline;}
div.column{display: inline-block; vertical-align: top; width: 50%;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
</style>



<style type="text/css">
code {
white-space: pre;
}
.sourceCode {
overflow: visible;
}
</style>
<style type="text/css" data-origin="pandoc">
pre > code.sourceCode { white-space: pre; position: relative; }
pre > code.sourceCode > span { line-height: 1.25; }
pre > code.sourceCode > span:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode > span { color: inherit; text-decoration: inherit; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
pre > code.sourceCode { white-space: pre-wrap; }
pre > code.sourceCode > span { display: inline-block; text-indent: -5em; padding-left: 5em; }
}
pre.numberSource code
{ counter-reset: source-line 0; }
pre.numberSource code > span
{ position: relative; left: -4em; counter-increment: source-line; }
pre.numberSource code > span > a:first-child::before
{ content: counter(source-line);
position: relative; left: -1em; text-align: right; vertical-align: baseline;
border: none; display: inline-block;
-webkit-touch-callout: none; -webkit-user-select: none;
-khtml-user-select: none; -moz-user-select: none;
-ms-user-select: none; user-select: none;
padding: 0 4px; width: 4em;
color: #aaaaaa;
}
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa; padding-left: 4px; }
div.sourceCode
{ }
@media screen {
pre > code.sourceCode > span > a:first-child::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } 
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.at { color: #7d9029; } 
code span.bn { color: #40a070; } 
code span.bu { color: #008000; } 
code span.cf { color: #007020; font-weight: bold; } 
code span.ch { color: #4070a0; } 
code span.cn { color: #880000; } 
code span.co { color: #60a0b0; font-style: italic; } 
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.do { color: #ba2121; font-style: italic; } 
code span.dt { color: #902000; } 
code span.dv { color: #40a070; } 
code span.er { color: #ff0000; font-weight: bold; } 
code span.ex { } 
code span.fl { color: #40a070; } 
code span.fu { color: #06287e; } 
code span.im { color: #008000; font-weight: bold; } 
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.kw { color: #007020; font-weight: bold; } 
code span.op { color: #666666; } 
code span.ot { color: #007020; } 
code span.pp { color: #bc7a00; } 
code span.sc { color: #4070a0; } 
code span.ss { color: #bb6688; } 
code span.st { color: #4070a0; } 
code span.va { color: #19177c; } 
code span.vs { color: #4070a0; } 
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } 
</style>
<script>
// apply pandoc div.sourceCode style to pre.sourceCode instead
(function() {
  var sheets = document.styleSheets;
  for (var i = 0; i < sheets.length; i++) {
    if (sheets[i].ownerNode.dataset["origin"] !== "pandoc") continue;
    try { var rules = sheets[i].cssRules; } catch (e) { continue; }
    var j = 0;
    while (j < rules.length) {
      var rule = rules[j];
      // check if there is a div.sourceCode rule
      if (rule.type !== rule.STYLE_RULE || rule.selectorText !== "div.sourceCode") {
        j++;
        continue;
      }
      var style = rule.style.cssText;
      // check if color or background-color is set
      if (rule.style.color === '' && rule.style.backgroundColor === '') {
        j++;
        continue;
      }
      // replace div.sourceCode by a pre.sourceCode rule
      sheets[i].deleteRule(j);
      sheets[i].insertRule('pre.sourceCode{' + style + '}', j);
    }
  }
})();
</script>



<style type="text/css">

div.csl-bib-body { }
div.csl-entry {
clear: both;
margin-bottom: 0em;
}
.hanging div.csl-entry {
margin-left:2em;
text-indent:-2em;
}
div.csl-left-margin {
min-width:2em;
float:left;
}
div.csl-right-inline {
margin-left:2em;
padding-left:1em;
}
div.csl-indent {
margin-left: 2em;
}
</style>

<style type="text/css">body {
background-color: #fff;
margin: 1em auto;
max-width: 700px;
overflow: visible;
padding-left: 2em;
padding-right: 2em;
font-family: "Open Sans", "Helvetica Neue", Helvetica, Arial, sans-serif;
font-size: 14px;
line-height: 1.35;
}
#TOC {
clear: both;
margin: 0 0 10px 10px;
padding: 4px;
width: 400px;
border: 1px solid #CCCCCC;
border-radius: 5px;
background-color: #f6f6f6;
font-size: 13px;
line-height: 1.3;
}
#TOC .toctitle {
font-weight: bold;
font-size: 15px;
margin-left: 5px;
}
#TOC ul {
padding-left: 40px;
margin-left: -1.5em;
margin-top: 5px;
margin-bottom: 5px;
}
#TOC ul ul {
margin-left: -2em;
}
#TOC li {
line-height: 16px;
}
table {
margin: 1em auto;
border-width: 1px;
border-color: #DDDDDD;
border-style: outset;
border-collapse: collapse;
}
table th {
border-width: 2px;
padding: 5px;
border-style: inset;
}
table td {
border-width: 1px;
border-style: inset;
line-height: 18px;
padding: 5px 5px;
}
table, table th, table td {
border-left-style: none;
border-right-style: none;
}
table thead, table tr.even {
background-color: #f7f7f7;
}
p {
margin: 0.5em 0;
}
blockquote {
background-color: #f6f6f6;
padding: 0.25em 0.75em;
}
hr {
border-style: solid;
border: none;
border-top: 1px solid #777;
margin: 28px 0;
}
dl {
margin-left: 0;
}
dl dd {
margin-bottom: 13px;
margin-left: 13px;
}
dl dt {
font-weight: bold;
}
ul {
margin-top: 0;
}
ul li {
list-style: circle outside;
}
ul ul {
margin-bottom: 0;
}
pre, code {
background-color: #f7f7f7;
border-radius: 3px;
color: #333;
white-space: pre-wrap; 
}
pre {
border-radius: 3px;
margin: 5px 0px 10px 0px;
padding: 10px;
}
pre:not([class]) {
background-color: #f7f7f7;
}
code {
font-family: Consolas, Monaco, 'Courier New', monospace;
font-size: 85%;
}
p > code, li > code {
padding: 2px 0px;
}
div.figure {
text-align: center;
}
img {
background-color: #FFFFFF;
padding: 2px;
border: 1px solid #DDDDDD;
border-radius: 3px;
border: 1px solid #CCCCCC;
margin: 0 5px;
}
h1 {
margin-top: 0;
font-size: 35px;
line-height: 40px;
}
h2 {
border-bottom: 4px solid #f7f7f7;
padding-top: 10px;
padding-bottom: 2px;
font-size: 145%;
}
h3 {
border-bottom: 2px solid #f7f7f7;
padding-top: 10px;
font-size: 120%;
}
h4 {
border-bottom: 1px solid #f7f7f7;
margin-left: 8px;
font-size: 105%;
}
h5, h6 {
border-bottom: 1px solid #ccc;
font-size: 105%;
}
a {
color: #0033dd;
text-decoration: none;
}
a:hover {
color: #6666ff; }
a:visited {
color: #800080; }
a:visited:hover {
color: #BB00BB; }
a[href^="http:"] {
text-decoration: underline; }
a[href^="https:"] {
text-decoration: underline; }

code > span.kw { color: #555; font-weight: bold; } 
code > span.dt { color: #902000; } 
code > span.dv { color: #40a070; } 
code > span.bn { color: #d14; } 
code > span.fl { color: #d14; } 
code > span.ch { color: #d14; } 
code > span.st { color: #d14; } 
code > span.co { color: #888888; font-style: italic; } 
code > span.ot { color: #007020; } 
code > span.al { color: #ff0000; font-weight: bold; } 
code > span.fu { color: #900; font-weight: bold; } 
code > span.er { color: #a61717; background-color: #e3d2d2; } 
</style>




</head>

<body>




<h1 class="title toc-ignore">Perform a time-course Model-Based Network
Meta-Analysis (MBNMA)</h1>
<h4 class="author">Hugo Pedder</h4>
<h4 class="date">2025-01-28</h4>



<div id="analysis-using-mb.run" class="section level2">
<h2>Analysis using <code>mb.run()</code></h2>
<p>MBNMA models are fitted using <code>mb.run()</code> and they model
treatment effects over time (e.g.Â days, weeks, months). This can just as
easily be performed on datasets with many different treatments (network
meta-analysis) as it can on datasets comparing only two treatments
(pairwise meta-analysis) - the syntax is the same.</p>
<p>An object or <code>class(&quot;mb.network&quot;)</code> must be provided as the
data for <code>mb.run()</code>. The key arguments within
<code>mb.run()</code> involve specifying the functional form used to
model the time-course, and the time-course parameters that comprise that
functional form.</p>
<div id="time-course-functions" class="section level3">
<h3>Time-course functions</h3>
<p>A number of different time-course functions can be fitted within
<code>MBNMAtime</code> and the specific forms of the time-course
parameters are defined by arguments within these functions, and this
allows for a wide variety of parameterizations and time-course
shapes.</p>
<p>For further details check the help files for each function
(e.g.Â <code>?tloglin()</code>). These functions, are then used as inputs
for the <code>fun</code> argument in <code>mb.run()</code>.</p>
<ul>
<li><code>tloglin()</code> - Log-linear function</li>
<li><code>titp()</code> - Integrated Two-Component Prediction (ITP)
function</li>
<li><code>temax()</code> - Emax function</li>
<li><code>tpoly()</code> - Polynomial function (e.g.Â linear,
quadratic)</li>
<li><code>tfpoly()</code> - Fractional polynomial function, as proposed
previously for time-course NMA by Jansen <span class="citation">(2015)</span>.</li>
<li><code>tspline()</code> - Spline functions (includes B-splines,
restricted cubic splines, natural splines and piecewise linear
splines)</li>
<li><code>tuser()</code> - A time-course function that can be explicitly
defined by the user</li>
</ul>
<p>Time-course parameters within time-course functions are each defined
by two arguments:</p>
<p><code>pool</code> is used to define the approach used for the pooling
of a given time-course parameter and can either of:</p>
<ul>
<li><code>&quot;rel&quot;</code> indicates that relative effects (or mean
differences) should be pooled for this time-course parameter. This
preserves randomisation within included studies, are likely to vary less
between studies (only due to effect modification), and allow for testing
of consistency between direct and indirect evidence. Pooling follows the
general approach for Network Meta-Analysis proposed by Lu and Ades <span class="citation">(2004)</span>.</li>
<li><code>&quot;abs&quot;</code> indicates that study arms should be pooled across
the whole network for this time-course parameter <strong>independently
of assigned treatment</strong>. This implies using a single absolute
value across the network for this time-course parameter, and may
therefore be making strong assumptions of similarity between
studies.</li>
</ul>
<p><code>method</code> is used to define the model used for
meta-analysis for a given time-course parameter and can take either
of:</p>
<ul>
<li><code>&quot;common&quot;</code> implies that all studies estimate the same
true effect (sometimes called a âfixed effectâ meta-analysis)</li>
<li><code>&quot;random&quot;</code> implies that all studies estimate a separate
true effect, but that each of these true effects vary randomly around a
true mean effect. This approach allows for modelling of between-study
heterogeneity.</li>
</ul>
<p>Specifying pooling relative effects on all time-course parameters
would imply performing a contrast-based synthesis, whereas specifying
pooling absolute effects on all of them would imply performing an
arm-based synthesis. There has been substantial discussion in the
literature regarding the strengths and limitations of both these
approaches <span class="citation">(Dias and Ades 2016; Hong et al. 2016;
Karahalios et al. 2017)</span>.</p>
<p>Additional arguments within the function may also be used to specify
the degree (e.g.Â for polynomials) or the number of knots or knot
placement for splines.</p>
<div id="splines-and-knots" class="section level4">
<h4>Splines and <code>knots</code></h4>
<p>For a more flexible time-course shape, various different splines can
be fitted to the data by using <code>tspline()</code>. This model is
very flexible and can allow for a variety of non-monotonic time-course
relationships, though parameters can be difficult to interpret and the
resulting time-course shape is often best visualised by calculating and
plotting predictions <a href="predictions-5.html">Prediction</a>.</p>
<p>To fit this model, the number/location of knots (the points at which
the different spline pieces meet) should be specified. These can be
specified either as a number of equally spaced knots, using
<code>nknots</code>, or by specifying the specific knot locations on the
time scale in the dataset, using <code>knots</code>. Note that by
default, a boundary knot will be placed at the maximum of the range of
time-points to limit the function extrapolating to extreme values.</p>
<div class="sourceCode" id="cb1"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb1-1"><a href="#cb1-1" tabindex="-1"></a><span class="co"># 3 equally spaced knots</span></span>
<span id="cb1-2"><a href="#cb1-2" tabindex="-1"></a><span class="fu">tspline</span>(<span class="at">type=</span><span class="st">&quot;bs&quot;</span>, <span class="at">nknots=</span><span class="dv">3</span>)</span>
<span id="cb1-3"><a href="#cb1-3" tabindex="-1"></a> </span>
<span id="cb1-4"><a href="#cb1-4" tabindex="-1"></a><span class="co"># knots at times of 2, 5 and 8</span></span>
<span id="cb1-5"><a href="#cb1-5" tabindex="-1"></a><span class="fu">tspline</span>(<span class="at">type=</span><span class="st">&quot;bs&quot;</span>, <span class="at">knots=</span><span class="fu">c</span>(<span class="dv">2</span>,<span class="dv">5</span>,<span class="dv">8</span>))</span></code></pre></div>
</div>
<div id="choosing-a-time-course-function" class="section level4">
<h4>Choosing a time-course function</h4>
<p>Choice of time-course function involves a combination of data-driven,
statistical information (plots, model fit statistics) and
clinical/biological plausibility. <code>timeplot()</code> and
<code>binplot()</code> functions can be used to observe the how the data
differs at different time-points. This can help to understand, for
example, whether the data monotonically increases or decreases, or
whether there is a turning point or multiple turning-points within the
time-course, and at which follow-up time(s) this might occur. This can
also be guided by a clinical/biological knowledge/expectation of the
shape of the time-course outside of the range of time-points for which
data are available.</p>
<p>However, once several potential candidate time-course functions have
been identified, selection between them (and of the specific
specification of the time-course parameters in terms of absolute or
relative effects) is best achieved using model fit statistics
(e.g.Â Deviance Information Criterion (DIC), residual deviance).</p>
</div>
</div>
<div id="output" class="section level3">
<h3>Output</h3>
<p><code>mb.run()</code> returns an object of
<code>class(c(&quot;mbnma&quot;, &quot;rjags&quot;))</code>. <code>summary()</code> provides
summary estimates of posterior densities for different parameters in the
model, with some explanation regarding the way in which the model has
been defined. Estimates are automatically reported for parameters of
interest depending on the model specification (unless otherwise
specified in <code>parameters.to.save</code>). Nodes that are
automatically monitored (if present in the model) have the following
interpretation:</p>
<div id="parameters-modelled-using-relative-effects" class="section level4">
<h4>Parameters modelled using relative effects</h4>
<p>If pooling is relative (e.g.Â <code>pool.1=&quot;rel&quot;</code>) for a given
parameter then the named parameter (e.g.Â <code>emax</code>) or a
numbered <code>d</code> parameter (e.g.Â <code>d.1</code>) corresponds to
the pooled relative effect (or mean difference) for a given treatment
compared to the network reference treatment for this time-course
parameter.</p>
<p><code>sd.</code> followed by a named (e.g.Â <code>emax</code>,
<code>beta.1</code>) is the between-study SD (heterogeneity) for
relative effects, reported if pooling for a time-course parameter is
relative (e.g.Â <code>pool.1=&quot;rel&quot;</code>) <em>and</em> the method for
synthesis is random (e.g.Â <code>method.1=&quot;random</code>).</p>
<p>If class effects are modelled, parameters for classes are represented
by the upper case name of the time-course parameter they correspond to.
For example if <code>class.effect=list(emax=&quot;random&quot;)</code>, relative
class effects will be represented by <code>EMAX</code>. The SD of the
class effect (e.g.Â <code>sd.EMAX</code>, <code>sd.BETA.1</code>) is the
SD of treatments within a class for the time-course parameter they
correspond to.</p>
</div>
<div id="parameters-modelled-using-absolute-effects" class="section level4">
<h4>Parameters modelled using absolute effects</h4>
<p>If pooling is absolute (e.g.Â <code>pool.1=&quot;abs&quot;</code>) for a given
parameter then the named parameter (e.g.Â <code>emax</code>) or a
numbered <code>beta</code> parameter (e.g.Â <code>beta.1</code>)
corresponds to the estimated absolute effect for this time-course
parameter.</p>
<p>For an absolute time-course parameter if the corresponding method is
common (e.g.Â <code>method.1=&quot;common&quot;</code>) the parameter corresponds
to a single common parameter estimated across all studies and
treatments. If the corresponding method is random
(e.g.Â <code>method.1=&quot;random&quot;</code>) then parameter is a mean effect
around which the study-level absolute effects vary with SD corresponding
to <code>sd.</code> followed by the named parameter
(e.g.Â <code>sd.emax</code>, <code>sd.beta.1</code>).</p>
</div>
<div id="other-model-parameters" class="section level4">
<h4>Other model parameters</h4>
<p><code>rho</code> is the correlation coefficient for correlation
between time-points. Its interpretation will differ depending on the
covariance structure specified in <code>covar</code>.</p>
<p><code>totresdev</code> is residual deviance of the model and
<code>deviance</code> is the deviance of the model. Model fit statistics
for <code>pD</code> (effective number of parameters) and
<code>DIC</code> (Deviance Information Criterion) are also reported,
with an explanation as to how they have been calculated.</p>
</div>
<div id="examples" class="section level4">
<h4>Examples</h4>
<p>An example MBNMA of the alogliptin dataset using a linear time-course
function and common treatment effects that pool relative effects and
assumes consistency between direct and indirect evidence can be
performed as follows:</p>
<div class="sourceCode" id="cb2"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb2-1"><a href="#cb2-1" tabindex="-1"></a><span class="co"># Prepare data using the alogliptin dataset</span></span>
<span id="cb2-2"><a href="#cb2-2" tabindex="-1"></a>network.alog <span class="ot">&lt;-</span> <span class="fu">mb.network</span>(alog_pcfb, <span class="at">reference =</span> <span class="st">&quot;placebo&quot;</span>)</span>
<span id="cb2-3"><a href="#cb2-3" tabindex="-1"></a><span class="co">#&gt; Studies reporting change from baseline automatically identified from the data</span></span>
<span id="cb2-4"><a href="#cb2-4" tabindex="-1"></a></span>
<span id="cb2-5"><a href="#cb2-5" tabindex="-1"></a><span class="co"># Run a linear time-course MBNMA</span></span>
<span id="cb2-6"><a href="#cb2-6" tabindex="-1"></a>mbnma <span class="ot">&lt;-</span> <span class="fu">mb.run</span>(network.alog, <span class="at">fun=</span><span class="fu">tpoly</span>(<span class="at">degree=</span><span class="dv">1</span>, <span class="at">pool.1=</span><span class="st">&quot;rel&quot;</span>, <span class="at">method.1=</span><span class="st">&quot;common&quot;</span>))</span></code></pre></div>
<div class="sourceCode" id="cb3"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb3-1"><a href="#cb3-1" tabindex="-1"></a><span class="fu">summary</span>(mbnma)</span>
<span id="cb3-2"><a href="#cb3-2" tabindex="-1"></a><span class="co">#&gt; ========================================</span></span>
<span id="cb3-3"><a href="#cb3-3" tabindex="-1"></a><span class="co">#&gt; Time-course MBNMA</span></span>
<span id="cb3-4"><a href="#cb3-4" tabindex="-1"></a><span class="co">#&gt; ========================================</span></span>
<span id="cb3-5"><a href="#cb3-5" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb3-6"><a href="#cb3-6" tabindex="-1"></a><span class="co">#&gt; Time-course function: poly (degree = 1)</span></span>
<span id="cb3-7"><a href="#cb3-7" tabindex="-1"></a><span class="co">#&gt; Data modelled without intercept (change from baseline data assumed)</span></span>
<span id="cb3-8"><a href="#cb3-8" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb3-9"><a href="#cb3-9" tabindex="-1"></a><span class="co">#&gt; beta.1 parameter</span></span>
<span id="cb3-10"><a href="#cb3-10" tabindex="-1"></a><span class="co">#&gt; Pooling: relative effects</span></span>
<span id="cb3-11"><a href="#cb3-11" tabindex="-1"></a><span class="co">#&gt; Method: common treatment effects</span></span>
<span id="cb3-12"><a href="#cb3-12" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb3-13"><a href="#cb3-13" tabindex="-1"></a><span class="co">#&gt; |Treatment |Parameter |  Median|    2.5%|   97.5%|</span></span>
<span id="cb3-14"><a href="#cb3-14" tabindex="-1"></a><span class="co">#&gt; |:---------|:---------|-------:|-------:|-------:|</span></span>
<span id="cb3-15"><a href="#cb3-15" tabindex="-1"></a><span class="co">#&gt; |placebo   |d.1[1]    |  0.0000|  0.0000|  0.0000|</span></span>
<span id="cb3-16"><a href="#cb3-16" tabindex="-1"></a><span class="co">#&gt; |alog_6.25 |d.1[2]    | -0.0347| -0.0376| -0.0318|</span></span>
<span id="cb3-17"><a href="#cb3-17" tabindex="-1"></a><span class="co">#&gt; |alog_12.5 |d.1[3]    | -0.0423| -0.0440| -0.0404|</span></span>
<span id="cb3-18"><a href="#cb3-18" tabindex="-1"></a><span class="co">#&gt; |alog_25   |d.1[4]    | -0.0450| -0.0467| -0.0432|</span></span>
<span id="cb3-19"><a href="#cb3-19" tabindex="-1"></a><span class="co">#&gt; |alog_50   |d.1[5]    | -0.0511| -0.0539| -0.0483|</span></span>
<span id="cb3-20"><a href="#cb3-20" tabindex="-1"></a><span class="co">#&gt; |alog_100  |d.1[6]    | -0.0485| -0.0664| -0.0297|</span></span>
<span id="cb3-21"><a href="#cb3-21" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb3-22"><a href="#cb3-22" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb3-23"><a href="#cb3-23" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb3-24"><a href="#cb3-24" tabindex="-1"></a><span class="co">#&gt; Correlation between time points</span></span>
<span id="cb3-25"><a href="#cb3-25" tabindex="-1"></a><span class="co">#&gt; Covariance structure: varadj </span></span>
<span id="cb3-26"><a href="#cb3-26" tabindex="-1"></a><span class="co">#&gt; Rho assigned a numeric value: 0</span></span>
<span id="cb3-27"><a href="#cb3-27" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb3-28"><a href="#cb3-28" tabindex="-1"></a><span class="co">#&gt; #### Model Fit Statistics ####</span></span>
<span id="cb3-29"><a href="#cb3-29" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb3-30"><a href="#cb3-30" tabindex="-1"></a><span class="co">#&gt; Effective number of parameters:</span></span>
<span id="cb3-31"><a href="#cb3-31" tabindex="-1"></a><span class="co">#&gt; pD calculated using the Kullback-Leibler divergence = 19</span></span>
<span id="cb3-32"><a href="#cb3-32" tabindex="-1"></a><span class="co">#&gt; Deviance = 4502</span></span>
<span id="cb3-33"><a href="#cb3-33" tabindex="-1"></a><span class="co">#&gt; Residual deviance = 5449</span></span>
<span id="cb3-34"><a href="#cb3-34" tabindex="-1"></a><span class="co">#&gt; Deviance Information Criterion (DIC) = 4521</span></span></code></pre></div>
<p>For this model, the <code>d.1</code> parameters correspond to the 1st
polynomial coefficient, and therefore are the linear gradient of the
response over time for each treatment versus <code>placebo</code> -
i.e.Â the mean difference for the change in efficacy for each treatment
versus <code>placebo</code>. However, note that the residual deviance of
the model is very high, suggesting (as we might expect) that this linear
time-course function is a poor fit.</p>
<p>We may want to fit a more complex time-course function with two
time-course parameters, such as an Emax function, yet limitations in the
data might require that we make an assumption that one of the parameters
does not vary by treatment. We can specify this by setting
<code>pool</code> to be equal to <code>&quot;abs&quot;</code> for any parameters
we choose.</p>
<div class="sourceCode" id="cb4"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb4-1"><a href="#cb4-1" tabindex="-1"></a><span class="co"># Run an Emax time-course MBNMA with two parameters</span></span>
<span id="cb4-2"><a href="#cb4-2" tabindex="-1"></a>mbnma <span class="ot">&lt;-</span> <span class="fu">mb.run</span>(network.alog, <span class="at">fun=</span><span class="fu">temax</span>(</span>
<span id="cb4-3"><a href="#cb4-3" tabindex="-1"></a>  <span class="at">pool.emax =</span> <span class="st">&quot;rel&quot;</span>, <span class="at">method.emax=</span><span class="st">&quot;common&quot;</span>,</span>
<span id="cb4-4"><a href="#cb4-4" tabindex="-1"></a>  <span class="at">pool.et50 =</span> <span class="st">&quot;abs&quot;</span>, <span class="at">method.et50=</span><span class="st">&quot;common&quot;</span></span>
<span id="cb4-5"><a href="#cb4-5" tabindex="-1"></a>))</span>
<span id="cb4-6"><a href="#cb4-6" tabindex="-1"></a><span class="co">#&gt; &#39;et50&#39; parameters must take positive values.</span></span>
<span id="cb4-7"><a href="#cb4-7" tabindex="-1"></a><span class="co">#&gt;  Default half-normal prior restricts posterior to positive values.</span></span></code></pre></div>
<div class="sourceCode" id="cb5"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb5-1"><a href="#cb5-1" tabindex="-1"></a><span class="fu">summary</span>(mbnma)</span>
<span id="cb5-2"><a href="#cb5-2" tabindex="-1"></a><span class="co">#&gt; ========================================</span></span>
<span id="cb5-3"><a href="#cb5-3" tabindex="-1"></a><span class="co">#&gt; Time-course MBNMA</span></span>
<span id="cb5-4"><a href="#cb5-4" tabindex="-1"></a><span class="co">#&gt; ========================================</span></span>
<span id="cb5-5"><a href="#cb5-5" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb5-6"><a href="#cb5-6" tabindex="-1"></a><span class="co">#&gt; Time-course function: emax</span></span>
<span id="cb5-7"><a href="#cb5-7" tabindex="-1"></a><span class="co">#&gt; Data modelled without intercept (change from baseline data assumed)</span></span>
<span id="cb5-8"><a href="#cb5-8" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb5-9"><a href="#cb5-9" tabindex="-1"></a><span class="co">#&gt; emax parameter</span></span>
<span id="cb5-10"><a href="#cb5-10" tabindex="-1"></a><span class="co">#&gt; Pooling: relative effects</span></span>
<span id="cb5-11"><a href="#cb5-11" tabindex="-1"></a><span class="co">#&gt; Method: common treatment effects</span></span>
<span id="cb5-12"><a href="#cb5-12" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb5-13"><a href="#cb5-13" tabindex="-1"></a><span class="co">#&gt; |Treatment |Parameter |  Median|    2.5%|   97.5%|</span></span>
<span id="cb5-14"><a href="#cb5-14" tabindex="-1"></a><span class="co">#&gt; |:---------|:---------|-------:|-------:|-------:|</span></span>
<span id="cb5-15"><a href="#cb5-15" tabindex="-1"></a><span class="co">#&gt; |placebo   |emax[1]   |  0.0000|  0.0000|  0.0000|</span></span>
<span id="cb5-16"><a href="#cb5-16" tabindex="-1"></a><span class="co">#&gt; |alog_6.25 |emax[2]   | -0.5885| -0.6537| -0.5243|</span></span>
<span id="cb5-17"><a href="#cb5-17" tabindex="-1"></a><span class="co">#&gt; |alog_12.5 |emax[3]   | -0.7758| -0.8171| -0.7356|</span></span>
<span id="cb5-18"><a href="#cb5-18" tabindex="-1"></a><span class="co">#&gt; |alog_25   |emax[4]   | -0.8450| -0.8869| -0.8043|</span></span>
<span id="cb5-19"><a href="#cb5-19" tabindex="-1"></a><span class="co">#&gt; |alog_50   |emax[5]   | -0.9653| -1.0373| -0.9006|</span></span>
<span id="cb5-20"><a href="#cb5-20" tabindex="-1"></a><span class="co">#&gt; |alog_100  |emax[6]   | -0.8280| -1.0888| -0.5639|</span></span>
<span id="cb5-21"><a href="#cb5-21" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb5-22"><a href="#cb5-22" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb5-23"><a href="#cb5-23" tabindex="-1"></a><span class="co">#&gt; et50 parameter</span></span>
<span id="cb5-24"><a href="#cb5-24" tabindex="-1"></a><span class="co">#&gt; Pooling: absolute effects</span></span>
<span id="cb5-25"><a href="#cb5-25" tabindex="-1"></a><span class="co">#&gt; Method: common treatment effects</span></span>
<span id="cb5-26"><a href="#cb5-26" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb5-27"><a href="#cb5-27" tabindex="-1"></a><span class="co">#&gt; |Treatment |Parameter | Median|   2.5%|  97.5%|</span></span>
<span id="cb5-28"><a href="#cb5-28" tabindex="-1"></a><span class="co">#&gt; |:---------|:---------|------:|------:|------:|</span></span>
<span id="cb5-29"><a href="#cb5-29" tabindex="-1"></a><span class="co">#&gt; |placebo   |et50      | 5.1911| 4.8031| 5.6011|</span></span>
<span id="cb5-30"><a href="#cb5-30" tabindex="-1"></a><span class="co">#&gt; |alog_6.25 |et50      | 5.1911| 4.8031| 5.6011|</span></span>
<span id="cb5-31"><a href="#cb5-31" tabindex="-1"></a><span class="co">#&gt; |alog_12.5 |et50      | 5.1911| 4.8031| 5.6011|</span></span>
<span id="cb5-32"><a href="#cb5-32" tabindex="-1"></a><span class="co">#&gt; |alog_25   |et50      | 5.1911| 4.8031| 5.6011|</span></span>
<span id="cb5-33"><a href="#cb5-33" tabindex="-1"></a><span class="co">#&gt; |alog_50   |et50      | 5.1911| 4.8031| 5.6011|</span></span>
<span id="cb5-34"><a href="#cb5-34" tabindex="-1"></a><span class="co">#&gt; |alog_100  |et50      | 5.1911| 4.8031| 5.6011|</span></span>
<span id="cb5-35"><a href="#cb5-35" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb5-36"><a href="#cb5-36" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb5-37"><a href="#cb5-37" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb5-38"><a href="#cb5-38" tabindex="-1"></a><span class="co">#&gt; Correlation between time points</span></span>
<span id="cb5-39"><a href="#cb5-39" tabindex="-1"></a><span class="co">#&gt; Covariance structure: varadj </span></span>
<span id="cb5-40"><a href="#cb5-40" tabindex="-1"></a><span class="co">#&gt; Rho assigned a numeric value: 0</span></span>
<span id="cb5-41"><a href="#cb5-41" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb5-42"><a href="#cb5-42" tabindex="-1"></a><span class="co">#&gt; #### Model Fit Statistics ####</span></span>
<span id="cb5-43"><a href="#cb5-43" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb5-44"><a href="#cb5-44" tabindex="-1"></a><span class="co">#&gt; Effective number of parameters:</span></span>
<span id="cb5-45"><a href="#cb5-45" tabindex="-1"></a><span class="co">#&gt; pD calculated using the Kullback-Leibler divergence = 20</span></span>
<span id="cb5-46"><a href="#cb5-46" tabindex="-1"></a><span class="co">#&gt; Deviance = 88</span></span>
<span id="cb5-47"><a href="#cb5-47" tabindex="-1"></a><span class="co">#&gt; Residual deviance = 1035</span></span>
<span id="cb5-48"><a href="#cb5-48" tabindex="-1"></a><span class="co">#&gt; Deviance Information Criterion (DIC) = 107</span></span></code></pre></div>
<p>In this case, the parameters are named following the Emax function
specification. <code>emax</code> corresponds to the maximum effect for
each treatment versus <code>placebo</code> (interpretable as a mean
difference versus <code>placebo</code>), whereas <code>et50</code> is
the log of the time at which 50% of the maximum response is achieved,
<strong>across all treatments in the network</strong>. This assumes
conditional constancy of absolute effects for this time-course
parameter, which is typically a strong assumption. However, if there
were limited data with which to inform this parameter (e.g.Â at earlier
time-points) then such an assumption might be necessary, with the caveat
that interpolation of response at time-points informed by this parameter
may be more susceptible to bias. Further exploration of the degree of
data required for reliable estimation of time-course parameters is given
in Pedder et al. <span class="citation">(2020)</span>.</p>
</div>
</div>
<div id="additional-model-specification-with-mb.run" class="section level3">
<h3>Additional model specification with <code>mb.run()</code></h3>
<div id="correlation-between-time-points" class="section level4">
<h4>Correlation between time points</h4>
<p>Within-study correlation between time points can easily be modeled
using <code>mb.run()</code>, though this requires some additional
considerations. The simplest approach is to incorporate correlation by
using a variance adjustment <span class="citation">(Jansen, Vieira, and
Cope 2015)</span>. This avoids the need to use a multivariate normal
likelihood (which is slow to run), and it assumes a common correlation
between neighbouring time-points. This is achieved by using the argument
<code>covar=&quot;varadj&quot;</code>, which is the default in
<code>mb.run()</code>.</p>
<p>There are two alternative covariance structures can be modelled,
though these require fitting a multivariate normal likelihood and
therefore take longer to run. <code>covar=&quot;CS&quot;</code> specifies fitting
a Compound Symmetry covariance structure, whilst
<code>covar=&quot;AR1&quot;</code> specifies fitting an autoregressive AR1
covariance structure to the multivariate normal likelihood used for
modelling the correlation between multiple time points within a study
<span class="citation">(Kincaid 2005)</span>.</p>
<p>However, in addition to this, itâs also necessary to specify a value
for <code>rho</code>, and this can be assigned in one of two ways:</p>
<ul>
<li>Given as string representing a JAGS prior distribution <span class="citation">(Plummer 2017)</span>, which indicates that the
correlation should be estimated from the data. For example, to specify a
prior that the correlation between time-points will be between 0 and 1
with equal probability you could set <code>rho=&quot;dunif(0,1)&quot;</code>.</li>
<li>Given as a single numeric value, which indicates that the
correlation should be fixed to that value. For example, this value could
be estimated externally from another study using Individual Participant
Data. This could also be used to run a deterministic sensitivity
analysis using different fixed values of <code>rho</code>.</li>
</ul>
<div class="sourceCode" id="cb6"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb6-1"><a href="#cb6-1" tabindex="-1"></a><span class="co"># Using the COPD dataset</span></span>
<span id="cb6-2"><a href="#cb6-2" tabindex="-1"></a>network.copd <span class="ot">&lt;-</span> <span class="fu">mb.network</span>(copd)</span>
<span id="cb6-3"><a href="#cb6-3" tabindex="-1"></a><span class="co">#&gt; Reference treatment is `Placebo`</span></span>
<span id="cb6-4"><a href="#cb6-4" tabindex="-1"></a><span class="co">#&gt; Studies reporting change from baseline automatically identified from the data</span></span>
<span id="cb6-5"><a href="#cb6-5" tabindex="-1"></a></span>
<span id="cb6-6"><a href="#cb6-6" tabindex="-1"></a><span class="co"># Run an log-linear time-course MBNMA </span></span>
<span id="cb6-7"><a href="#cb6-7" tabindex="-1"></a><span class="co"># that accounts for correlation between time points using variance adjustment</span></span>
<span id="cb6-8"><a href="#cb6-8" tabindex="-1"></a>mbnma <span class="ot">&lt;-</span> <span class="fu">mb.run</span>(network.copd, </span>
<span id="cb6-9"><a href="#cb6-9" tabindex="-1"></a>                <span class="at">fun=</span><span class="fu">tloglin</span>(<span class="at">pool.rate=</span><span class="st">&quot;rel&quot;</span>, <span class="at">method.rate=</span><span class="st">&quot;random&quot;</span>),</span>
<span id="cb6-10"><a href="#cb6-10" tabindex="-1"></a>                <span class="at">rho=</span><span class="st">&quot;dunif(0,1)&quot;</span>, <span class="at">covar=</span><span class="st">&quot;varadj&quot;</span>)</span></code></pre></div>
<p>It is important to note that the covariance matrix must be positive
semi-definite. This may mean that in order to satisfy this requirement
for particular covariance matrix structures, the values that
<code>rho</code> can take are limited. <code>rho</code> must always be
bounded by -1 and 1, but even within this range some negative values for
<code>rho</code> can result in a non positive matrix, which can lead to
an error in the evaluation of the multivariate likelihood. If so, it may
be necessary to further restrict the prior distribution.</p>
</div>
<div id="link-function" class="section level4">
<h4>Link function</h4>
<p>Time-course MBNMA can only be used for continuous outcomes <em>or
those that can be summarised as continuous outcomes</em> (e.g.Â binary
data can be converted to log-odds for inclusion in the model). Typically
this means that users will analyse data using an identity link function,
the default given to the <code>link</code> argument in
<code>mb.run()</code>m which assumes an additive treatment effect
(e.g.Â mean difference).</p>
<p>However, by specifying <code>link=&quot;log&quot;</code> a user can model a log
link and therefore assume a multiplicative treatment effect. For
continuous data this models the treatment effect as a Ratio of Means
(RoM) <span class="citation">(Friedrich, Adhikari, and Beyene
2011)</span>. This also provides an advantage as the treatment effect is
scale independent (i.e.Â studies measuring the same outcome using
different measurement scales can be analysed simultaneously). However,
within-study treatment effects must all be positive (if all negative
then they can all be converted to positive and the treatment effects are
inverted), and change from baseline measures must be adjusted so that
they are also expressed as RoMs (log(follow-up) - log(baseline)) to
avoid combining additive and multiplicative assumptions within the same
analysis. Note that assuming a ratio effect in time-course models
implies very different effects over time to a model on the natural
scale. For example, a linear time-course model on the log scale implies
an exponential relationship on the natural scale.</p>
<p>An alternative approach for modelling a measurement scale-independent
treatment effect whilst still assuming additive treatment effects is to
perform the analysis using Standardised Mean Differences (SMD). Whilst
not strictly a different link function, this can be specified using
<code>link=&quot;smd&quot;</code>.</p>
<p>By default, <code>MBNMAtime</code> standardises treatment effects
using the pooled standard deviation (SD) at baseline in each study
(âstudy-specificâ SDs). However, a more robust approach to minimise bias
from estimation of study-specific SD is to use a âreferenceâ SD that is
the same for each scale included in the dataset. Such a reference could
be estimated from all the included studies within the dataset that
report outcomes on the scale (an âinternal reference SDâ), but the best
approach is to obtain a SD from an observational study <em>that is
specific to the target population of interest</em>.</p>
<p>Once this has been obtained for each scale, it can be included in the
original data frame as an additional variable, <code>standsd</code>. For
the analysis to be meaningful, <code>stansd</code> should be the same
for all arms within a study and for all studies that report the same
outcome. If this has been included in the dataset used to create an
<code>&quot;mb.network&quot;</code> object, then <code>sdscale=TRUE</code>
argument can be specified in <code>mbnma.run()</code> to indicate that
this variable should be used to standardise SMDs.</p>
<p>Note that for outputting results from a model using SMDs, results
should be back-transformed to a clinically relevant scale to make robust
interpretation. This can be done by multiplying the effect estimates or
predictions by the standard deviation of the relevant scale in the
population of interest. For further details of analysis of continuous
data that include discussion of both RoM and SMD see <span class="citation">(Daly et al. 2021)</span>.</p>
</div>
<div id="class-effects" class="section level4">
<h4>Class effects</h4>
<p>Shared effects between treatments within the network can be modelled
using class effects. This requires assuming that different treatments
have some sort of shared class effect, perhaps due to different (yet
clinically similar) doses of the same agent or different treatments with
a similar mechanism of action. One advantage of this is that class
effects can be used to connect relative effects between treatments in a
network that would be disconnected at the treatment level, but can be
connected via classes at the class level. However, it is important to
ensure that such an effect is clinically justifiable, as making these
assumptions risks introducing heterogeneity/inconsistency.</p>
<p>Class effects can only be applied to time-course parameters which
vary by treatment (<code>pool=&quot;rel&quot;</code>), and class effects are
modelled separately for each time-course parameter.</p>
<p>In <code>mb.run()</code> class effects are specified as a list, in
which each element is named by the time-course parameter on which it
should be modelled. The class effect for each time-course parameter can
be either <code>&quot;common&quot;</code>, in which the effects for each treatment
within the same class are constrained to a common class effect, or
<code>&quot;random&quot;</code>, in which the effects for each treatment within
the same class are assumed to be randomly distributed around a shared
class mean.</p>
<div class="sourceCode" id="cb7"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb7-1"><a href="#cb7-1" tabindex="-1"></a><span class="co"># Create network object of gout dataset</span></span>
<span id="cb7-2"><a href="#cb7-2" tabindex="-1"></a>network.gout <span class="ot">&lt;-</span> <span class="fu">mb.network</span>(goutSUA_CFBcomb)</span>
<span id="cb7-3"><a href="#cb7-3" tabindex="-1"></a></span>
<span id="cb7-4"><a href="#cb7-4" tabindex="-1"></a><span class="co"># Run a B-spline time-course MBNMA with a knot at 8 weeks follow-up</span></span>
<span id="cb7-5"><a href="#cb7-5" tabindex="-1"></a><span class="co"># Common class effect on beta.2, the 2nd spline coefficient</span></span>
<span id="cb7-6"><a href="#cb7-6" tabindex="-1"></a>mbnma <span class="ot">&lt;-</span> <span class="fu">mb.run</span>(network.gout, </span>
<span id="cb7-7"><a href="#cb7-7" tabindex="-1"></a>                <span class="at">fun=</span><span class="fu">tspline</span>(<span class="at">type=</span><span class="st">&quot;bs&quot;</span>, <span class="at">knots=</span><span class="dv">8</span>,</span>
<span id="cb7-8"><a href="#cb7-8" tabindex="-1"></a>                            <span class="at">pool.1 =</span> <span class="st">&quot;rel&quot;</span>, <span class="at">method.1=</span><span class="st">&quot;common&quot;</span>,</span>
<span id="cb7-9"><a href="#cb7-9" tabindex="-1"></a>                            <span class="at">pool.2=</span><span class="st">&quot;rel&quot;</span>, <span class="at">method.2=</span><span class="st">&quot;random&quot;</span>),</span>
<span id="cb7-10"><a href="#cb7-10" tabindex="-1"></a>                <span class="at">class.effect =</span> <span class="fu">list</span>(<span class="at">beta.2=</span><span class="st">&quot;common&quot;</span>))</span></code></pre></div>
<div class="sourceCode" id="cb8"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb8-1"><a href="#cb8-1" tabindex="-1"></a><span class="fu">summary</span>(mbnma)</span>
<span id="cb8-2"><a href="#cb8-2" tabindex="-1"></a><span class="co">#&gt; ========================================</span></span>
<span id="cb8-3"><a href="#cb8-3" tabindex="-1"></a><span class="co">#&gt; Time-course MBNMA</span></span>
<span id="cb8-4"><a href="#cb8-4" tabindex="-1"></a><span class="co">#&gt; ========================================</span></span>
<span id="cb8-5"><a href="#cb8-5" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb8-6"><a href="#cb8-6" tabindex="-1"></a><span class="co">#&gt; Time-course function: B-spline (knots = 8; degree = 1)</span></span>
<span id="cb8-7"><a href="#cb8-7" tabindex="-1"></a><span class="co">#&gt; Data modelled without intercept (change from baseline data assumed)</span></span>
<span id="cb8-8"><a href="#cb8-8" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb8-9"><a href="#cb8-9" tabindex="-1"></a><span class="co">#&gt; beta.1 parameter</span></span>
<span id="cb8-10"><a href="#cb8-10" tabindex="-1"></a><span class="co">#&gt; Pooling: relative effects</span></span>
<span id="cb8-11"><a href="#cb8-11" tabindex="-1"></a><span class="co">#&gt; Method: common treatment effects</span></span>
<span id="cb8-12"><a href="#cb8-12" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb8-13"><a href="#cb8-13" tabindex="-1"></a><span class="co">#&gt; |Treatment |Parameter |   Median|     2.5%|    97.5%|</span></span>
<span id="cb8-14"><a href="#cb8-14" tabindex="-1"></a><span class="co">#&gt; |:---------|:---------|--------:|--------:|--------:|</span></span>
<span id="cb8-15"><a href="#cb8-15" tabindex="-1"></a><span class="co">#&gt; |Plac      |d.1[1]    |   0.0000|   0.0000|   0.0000|</span></span>
<span id="cb8-16"><a href="#cb8-16" tabindex="-1"></a><span class="co">#&gt; |Allo_100  |d.1[2]    |  -1.1482|  -2.2317|  -0.0986|</span></span>
<span id="cb8-17"><a href="#cb8-17" tabindex="-1"></a><span class="co">#&gt; |Allo_200  |d.1[3]    |  -3.1065|  -3.3220|  -2.8907|</span></span>
<span id="cb8-18"><a href="#cb8-18" tabindex="-1"></a><span class="co">#&gt; |Allo_289  |d.1[4]    |  -4.4377|  -4.6122|  -4.2583|</span></span>
<span id="cb8-19"><a href="#cb8-19" tabindex="-1"></a><span class="co">#&gt; |Allo_400  |d.1[5]    | -10.4839| -11.6322|  -9.2313|</span></span>
<span id="cb8-20"><a href="#cb8-20" tabindex="-1"></a><span class="co">#&gt; |Arha_NA   |d.1[6]    |  -5.2466|  -5.8205|  -4.7003|</span></span>
<span id="cb8-21"><a href="#cb8-21" tabindex="-1"></a><span class="co">#&gt; |BCX4_140  |d.1[7]    |  -3.9476|  -4.2610|  -3.6272|</span></span>
<span id="cb8-22"><a href="#cb8-22" tabindex="-1"></a><span class="co">#&gt; |BCX4_18.5 |d.1[8]    |  -2.2184|  -2.6054|  -1.8320|</span></span>
<span id="cb8-23"><a href="#cb8-23" tabindex="-1"></a><span class="co">#&gt; |BCX4_240  |d.1[9]    |  -5.1085|  -5.4908|  -4.7172|</span></span>
<span id="cb8-24"><a href="#cb8-24" tabindex="-1"></a><span class="co">#&gt; |BCX4_80   |d.1[10]   |  -3.0722|  -3.4557|  -2.6842|</span></span>
<span id="cb8-25"><a href="#cb8-25" tabindex="-1"></a><span class="co">#&gt; |Benz_NA   |d.1[11]   | -12.6297| -13.5062| -11.7177|</span></span>
<span id="cb8-26"><a href="#cb8-26" tabindex="-1"></a><span class="co">#&gt; |Febu_140  |d.1[12]   |  -6.7155|  -6.8905|  -6.5349|</span></span>
<span id="cb8-27"><a href="#cb8-27" tabindex="-1"></a><span class="co">#&gt; |Febu_210  |d.1[13]   |  -8.1343|  -8.2255|  -8.0404|</span></span>
<span id="cb8-28"><a href="#cb8-28" tabindex="-1"></a><span class="co">#&gt; |Febu_25   |d.1[14]   |  -3.7478|  -3.9132|  -3.5774|</span></span>
<span id="cb8-29"><a href="#cb8-29" tabindex="-1"></a><span class="co">#&gt; |Febu_72.5 |d.1[15]   |  -5.7360|  -5.9101|  -5.5602|</span></span>
<span id="cb8-30"><a href="#cb8-30" tabindex="-1"></a><span class="co">#&gt; |RDEA_100  |d.1[16]   |  -1.7403|  -2.2229|  -1.2438|</span></span>
<span id="cb8-31"><a href="#cb8-31" tabindex="-1"></a><span class="co">#&gt; |RDEA_200  |d.1[17]   |  -3.3681|  -3.6573|  -3.0842|</span></span>
<span id="cb8-32"><a href="#cb8-32" tabindex="-1"></a><span class="co">#&gt; |RDEA_400  |d.1[18]   |  -4.3142|  -4.6001|  -4.0464|</span></span>
<span id="cb8-33"><a href="#cb8-33" tabindex="-1"></a><span class="co">#&gt; |RDEA_600  |d.1[19]   |  -6.3948|  -6.7293|  -6.0435|</span></span>
<span id="cb8-34"><a href="#cb8-34" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb8-35"><a href="#cb8-35" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb8-36"><a href="#cb8-36" tabindex="-1"></a><span class="co">#&gt; beta.2 parameter</span></span>
<span id="cb8-37"><a href="#cb8-37" tabindex="-1"></a><span class="co">#&gt; Pooling: relative effects</span></span>
<span id="cb8-38"><a href="#cb8-38" tabindex="-1"></a><span class="co">#&gt; Method: random treatment effects</span></span>
<span id="cb8-39"><a href="#cb8-39" tabindex="-1"></a><span class="co">#&gt; Class effects modelled for this parameter</span></span>
<span id="cb8-40"><a href="#cb8-40" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb8-41"><a href="#cb8-41" tabindex="-1"></a><span class="co">#&gt; |Treatment |Parameter |  Median|     2.5%|   97.5%|</span></span>
<span id="cb8-42"><a href="#cb8-42" tabindex="-1"></a><span class="co">#&gt; |:---------|:---------|-------:|--------:|-------:|</span></span>
<span id="cb8-43"><a href="#cb8-43" tabindex="-1"></a><span class="co">#&gt; |Plac      |d.2[1]    |  0.0000|   0.0000|  0.0000|</span></span>
<span id="cb8-44"><a href="#cb8-44" tabindex="-1"></a><span class="co">#&gt; |Allo_100  |d.2[2]    | 12.9684|   5.8526| 19.8121|</span></span>
<span id="cb8-45"><a href="#cb8-45" tabindex="-1"></a><span class="co">#&gt; |Allo_200  |d.2[3]    | 12.9684|   5.8526| 19.8121|</span></span>
<span id="cb8-46"><a href="#cb8-46" tabindex="-1"></a><span class="co">#&gt; |Allo_289  |d.2[4]    | 12.9684|   5.8526| 19.8121|</span></span>
<span id="cb8-47"><a href="#cb8-47" tabindex="-1"></a><span class="co">#&gt; |Allo_400  |d.2[5]    | 12.9684|   5.8526| 19.8121|</span></span>
<span id="cb8-48"><a href="#cb8-48" tabindex="-1"></a><span class="co">#&gt; |Arha_NA   |d.2[6]    |  0.2760| -63.9975| 61.9457|</span></span>
<span id="cb8-49"><a href="#cb8-49" tabindex="-1"></a><span class="co">#&gt; |BCX4_140  |d.2[7]    |  2.5687|  -4.1998|  9.5767|</span></span>
<span id="cb8-50"><a href="#cb8-50" tabindex="-1"></a><span class="co">#&gt; |BCX4_18.5 |d.2[8]    |  2.5687|  -4.1998|  9.5767|</span></span>
<span id="cb8-51"><a href="#cb8-51" tabindex="-1"></a><span class="co">#&gt; |BCX4_240  |d.2[9]    |  2.5687|  -4.1998|  9.5767|</span></span>
<span id="cb8-52"><a href="#cb8-52" tabindex="-1"></a><span class="co">#&gt; |BCX4_80   |d.2[10]   |  2.5687|  -4.1998|  9.5767|</span></span>
<span id="cb8-53"><a href="#cb8-53" tabindex="-1"></a><span class="co">#&gt; |Benz_NA   |d.2[11]   | 14.6265|  -0.7073| 29.2587|</span></span>
<span id="cb8-54"><a href="#cb8-54" tabindex="-1"></a><span class="co">#&gt; |Febu_140  |d.2[12]   | 10.2905|   4.3994| 16.3143|</span></span>
<span id="cb8-55"><a href="#cb8-55" tabindex="-1"></a><span class="co">#&gt; |Febu_210  |d.2[13]   | 10.2905|   4.3994| 16.3143|</span></span>
<span id="cb8-56"><a href="#cb8-56" tabindex="-1"></a><span class="co">#&gt; |Febu_25   |d.2[14]   | 10.2905|   4.3994| 16.3143|</span></span>
<span id="cb8-57"><a href="#cb8-57" tabindex="-1"></a><span class="co">#&gt; |Febu_72.5 |d.2[15]   | 10.2905|   4.3994| 16.3143|</span></span>
<span id="cb8-58"><a href="#cb8-58" tabindex="-1"></a><span class="co">#&gt; |RDEA_100  |d.2[16]   | 10.1000|   0.9415| 19.8264|</span></span>
<span id="cb8-59"><a href="#cb8-59" tabindex="-1"></a><span class="co">#&gt; |RDEA_200  |d.2[17]   | 10.1000|   0.9415| 19.8264|</span></span>
<span id="cb8-60"><a href="#cb8-60" tabindex="-1"></a><span class="co">#&gt; |RDEA_400  |d.2[18]   | 10.1000|   0.9415| 19.8264|</span></span>
<span id="cb8-61"><a href="#cb8-61" tabindex="-1"></a><span class="co">#&gt; |RDEA_600  |d.2[19]   | 10.1000|   0.9415| 19.8264|</span></span>
<span id="cb8-62"><a href="#cb8-62" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb8-63"><a href="#cb8-63" tabindex="-1"></a><span class="co">#&gt; Between-study SD modelled for this parameter:</span></span>
<span id="cb8-64"><a href="#cb8-64" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb8-65"><a href="#cb8-65" tabindex="-1"></a><span class="co">#&gt; |Parameter | Median|   2.5%| 97.5%|</span></span>
<span id="cb8-66"><a href="#cb8-66" tabindex="-1"></a><span class="co">#&gt; |:---------|------:|------:|-----:|</span></span>
<span id="cb8-67"><a href="#cb8-67" tabindex="-1"></a><span class="co">#&gt; |sd.beta.2 | 6.6065| 4.9666| 9.101|</span></span>
<span id="cb8-68"><a href="#cb8-68" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb8-69"><a href="#cb8-69" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb8-70"><a href="#cb8-70" tabindex="-1"></a><span class="co">#&gt; Class Effects</span></span>
<span id="cb8-71"><a href="#cb8-71" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb8-72"><a href="#cb8-72" tabindex="-1"></a><span class="co">#&gt; Class effects for beta.2</span></span>
<span id="cb8-73"><a href="#cb8-73" tabindex="-1"></a><span class="co">#&gt; Common (fixed) class effects</span></span>
<span id="cb8-74"><a href="#cb8-74" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb8-75"><a href="#cb8-75" tabindex="-1"></a><span class="co">#&gt; |Class |Parameter |  Median|     2.5%|   97.5%|</span></span>
<span id="cb8-76"><a href="#cb8-76" tabindex="-1"></a><span class="co">#&gt; |:-----|:---------|-------:|--------:|-------:|</span></span>
<span id="cb8-77"><a href="#cb8-77" tabindex="-1"></a><span class="co">#&gt; |Plac  |D.2[1]    |  0.0000|   0.0000|  0.0000|</span></span>
<span id="cb8-78"><a href="#cb8-78" tabindex="-1"></a><span class="co">#&gt; |Allo  |D.2[2]    | 12.9684|   5.8526| 19.8121|</span></span>
<span id="cb8-79"><a href="#cb8-79" tabindex="-1"></a><span class="co">#&gt; |Arha  |D.2[3]    |  0.2760| -63.9975| 61.9457|</span></span>
<span id="cb8-80"><a href="#cb8-80" tabindex="-1"></a><span class="co">#&gt; |BCX4  |D.2[4]    |  2.5687|  -4.1998|  9.5767|</span></span>
<span id="cb8-81"><a href="#cb8-81" tabindex="-1"></a><span class="co">#&gt; |Benz  |D.2[5]    | 14.6265|  -0.7073| 29.2587|</span></span>
<span id="cb8-82"><a href="#cb8-82" tabindex="-1"></a><span class="co">#&gt; |Febu  |D.2[6]    | 10.2905|   4.3994| 16.3143|</span></span>
<span id="cb8-83"><a href="#cb8-83" tabindex="-1"></a><span class="co">#&gt; |RDEA  |D.2[7]    | 10.1000|   0.9415| 19.8264|</span></span>
<span id="cb8-84"><a href="#cb8-84" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb8-85"><a href="#cb8-85" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb8-86"><a href="#cb8-86" tabindex="-1"></a><span class="co">#&gt; Correlation between time points</span></span>
<span id="cb8-87"><a href="#cb8-87" tabindex="-1"></a><span class="co">#&gt; Covariance structure: varadj </span></span>
<span id="cb8-88"><a href="#cb8-88" tabindex="-1"></a><span class="co">#&gt; Rho assigned a numeric value: 0</span></span>
<span id="cb8-89"><a href="#cb8-89" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb8-90"><a href="#cb8-90" tabindex="-1"></a><span class="co">#&gt; #### Model Fit Statistics ####</span></span>
<span id="cb8-91"><a href="#cb8-91" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb8-92"><a href="#cb8-92" tabindex="-1"></a><span class="co">#&gt; Effective number of parameters:</span></span>
<span id="cb8-93"><a href="#cb8-93" tabindex="-1"></a><span class="co">#&gt; pD calculated using the Kullback-Leibler divergence = 82</span></span>
<span id="cb8-94"><a href="#cb8-94" tabindex="-1"></a><span class="co">#&gt; Deviance = 119221</span></span>
<span id="cb8-95"><a href="#cb8-95" tabindex="-1"></a><span class="co">#&gt; Residual deviance = 119915</span></span>
<span id="cb8-96"><a href="#cb8-96" tabindex="-1"></a><span class="co">#&gt; Deviance Information Criterion (DIC) = 119302</span></span></code></pre></div>
<p>Mean class effects are given in the output as <code>D.2</code>
parameters. These can be interpreted as the relative effect of each
class versus the <code>Plac</code> (Placebo), for the 2nd spline
coefficient (<code>beta.2</code>). Note the number of <code>D.2</code>
parameters is therefore equal to the number of classes defined in the
dataset.</p>
</div>
</div>
<div id="additional-arguments" class="section level3">
<h3>Additional arguments</h3>
<p>Several additional arguments can be given to <code>mb.run()</code>
that require further explanation.</p>
<div id="priors" class="section level4">
<h4>Priors</h4>
<p>Default vague priors for the model are as follows:</p>
<p><span class="math display">\[
\begin{aligned}
  &amp;\alpha_{i} \sim N(0,10000)\\
  &amp;\boldsymbol{\mu}_{i} \sim N(0,10000)\\
  &amp;\boldsymbol{d}_{t} \sim N(0,10000)\\
  &amp;beta_{\phi} \sim N(0,10000)\\
  &amp;D_{\phi,c} \sim N(0,1000)\\
  &amp;\tau_{\phi} \sim N(0,400) \text{  limited to  } x \in
[0,\infty]\\
  &amp;\tau^D_{\phi} \sim N(0,400) \text{ limited to } x \in
[0,\infty]\\
\end{aligned}
\]</span></p>
<ul>
<li><span class="math inline">\(\alpha_i\)</span> is the response at
time=0 in study <span class="math inline">\(i\)</span></li>
<li><span class="math inline">\(\mu_i\)</span> is a vector of study
reference effects for each time-course parameter in study <span class="math inline">\(i\)</span>. Where only a single time-course
parameter is modelled using relative effects the prior is defined as
<span class="math inline">\(\mu_{i} \sim N(0,10000)\)</span>.</li>
<li><span class="math inline">\(\boldsymbol{d}_{t}\)</span> is a vector
of pooled relative effects for treatment <span class="math inline">\(t\)</span> whose length is the number of
time-course parameters in the model. Where only a single time-course
parameter is modelled using relative effects the prior is defined as
<span class="math inline">\(d_{t} \sim N(0,10000)\)</span>.</li>
<li><span class="math inline">\(\beta_{\phi}\)</span> is the absolute
effect for time-course parameter <span class="math inline">\(\phi\)</span> modelled independently of
treatment</li>
<li><span class="math inline">\(D_{\phi,c}\)</span> is the class
relative effect for time-course parameter <span class="math inline">\(\phi\)</span> in class <span class="math inline">\(c\)</span></li>
<li><span class="math inline">\(\tau_{\phi}\)</span> is the
between-study SD for time-course parameter <span class="math inline">\(\phi\)</span></li>
<li><span class="math inline">\(\tau^D_{\phi}\)</span> is the
within-class SD for time-course parameter <span class="math inline">\(\phi\)</span></li>
</ul>
<p>Users may wish to change these, perhaps in order to use more/less
informative priors or different prior distributions (e.g.Â log-normal
prior rather than a truncated normal for ET50 in an Emax model).
However, it may also be because the default prior distributions in some
models can lead to errors when compiling/updating models if the prior
includes extremely implausible values.</p>
<p>This can be more likely for certain types of models. For example some
prior distributions may generate results that are too extreme for JAGS
to compute, such as for time-course parameters that are powers
(e.g.Â Emax functions with a Hill parameter or power parameters in
fractional polynomials).</p>
<p>If the model fails during compilation/updating (i.e.Â due to a problem
in JAGS), <code>mb.run()</code> will generate an error and return a list
of arguments that <code>mb.run()</code> used to generate the model.
Within this (as within a model that has run successfully), the priors
used by the model (in JAGS syntax) are stored within
<code>&quot;model.arg&quot;</code>.</p>
<p>In this way a model can first be run with vague priors and then rerun
with different priors, perhaps to allow successful computation, perhaps
to provide more informative priors, or perhaps to run a sensitivity
analysis with different priors.</p>
<p>To change priors within a model, a list of replacements can be
provided to <code>priors</code> in <code>mb.run()</code>. The name of
each element is the name of the parameter to change (without indices)
and the value of the element is the JAGS distribution to use for the
prior. See the JAGS Manual <span class="citation">(2017)</span> for
syntax details regarding specifying distributions. This can include
censoring or truncation if desired. Only the priors to be changed need
to be specified - priors for parameters that arenât specified will take
default values. Note that in JAGS, normal distributions are specified
using precision (1/variance) rather than SD.</p>
<p>For example, we may wish to specify a tighter prior for the
between-study SD:</p>
<div class="sourceCode" id="cb9"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb9-1"><a href="#cb9-1" tabindex="-1"></a>mbnma <span class="ot">&lt;-</span> <span class="fu">mb.run</span>(network.copd, </span>
<span id="cb9-2"><a href="#cb9-2" tabindex="-1"></a>                <span class="at">fun=</span><span class="fu">tloglin</span>(<span class="at">pool.rate=</span><span class="st">&quot;rel&quot;</span>, <span class="at">method.rate=</span><span class="st">&quot;random&quot;</span>),</span>
<span id="cb9-3"><a href="#cb9-3" tabindex="-1"></a>                <span class="at">priors=</span><span class="fu">list</span>(<span class="at">rate=</span><span class="st">&quot;dnorm(0,2) T(0,)&quot;</span>))</span></code></pre></div>
<p>Different prior distributions can be assigned for different indices
of a parameter by specifying the list element for a parameter as a
character vector. This allows (for example) for the user to fit specific
priors for specific treatments. The length of this vector must be equal
to the number of indices of the parameter. The ordering will also be
important - for example for treatment-specific priors the order of the
elements within the vector must match the order of the treatments in the
network.</p>
<p>For example we might have differnt beliefs about the long-term
efficacy of a treatment for which there is no long-term data available
in the dataset. In the COPD dataset we have longer term data (up to 52
weeks) on Tiotropium, but much shorter follow-up data (up to 26 weeks)
on Aclidinium.</p>
<p>We might believe (e.g.Â based on clincial opinion) that the efficacy
of Aclidinium returns towards baseline at longer follow-up. We could
model this using a B-spline and providing informative priors only to the
parameters controlling the spline for Aclidinium at later follow-up:</p>
<div class="sourceCode" id="cb10"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb10-1"><a href="#cb10-1" tabindex="-1"></a><span class="co"># Define informative priors for spline parameters</span></span>
<span id="cb10-2"><a href="#cb10-2" tabindex="-1"></a>spline.priors <span class="ot">&lt;-</span> <span class="fu">list</span>(</span>
<span id="cb10-3"><a href="#cb10-3" tabindex="-1"></a>  <span class="at">d.3 =</span> <span class="fu">c</span>(</span>
<span id="cb10-4"><a href="#cb10-4" tabindex="-1"></a>  <span class="at">Aclidinium=</span><span class="st">&quot;dnorm(-0.5, 100)&quot;</span>, </span>
<span id="cb10-5"><a href="#cb10-5" tabindex="-1"></a>  <span class="at">Tiotropium=</span><span class="st">&quot;dnorm(0, 0.0001)&quot;</span></span>
<span id="cb10-6"><a href="#cb10-6" tabindex="-1"></a>  ),</span>
<span id="cb10-7"><a href="#cb10-7" tabindex="-1"></a>  <span class="at">d.4 =</span> <span class="fu">c</span>(</span>
<span id="cb10-8"><a href="#cb10-8" tabindex="-1"></a>  <span class="at">Aclidinium=</span><span class="st">&quot;dnorm(0, 100)&quot;</span>, </span>
<span id="cb10-9"><a href="#cb10-9" tabindex="-1"></a>  <span class="at">Tiotropium=</span><span class="st">&quot;dnorm(0, 0.0001)&quot;</span></span>
<span id="cb10-10"><a href="#cb10-10" tabindex="-1"></a>  ))</span>
<span id="cb10-11"><a href="#cb10-11" tabindex="-1"></a></span>
<span id="cb10-12"><a href="#cb10-12" tabindex="-1"></a><span class="co"># Using the COPD dataset with a B-spline MBNMA</span></span>
<span id="cb10-13"><a href="#cb10-13" tabindex="-1"></a>mbnma <span class="ot">&lt;-</span> <span class="fu">mb.run</span>(network.copd, <span class="at">fun=</span><span class="fu">tspline</span>(<span class="at">degree=</span><span class="dv">2</span>, <span class="at">knots=</span><span class="fu">c</span>(<span class="dv">5</span>,<span class="dv">26</span>)),</span>
<span id="cb10-14"><a href="#cb10-14" tabindex="-1"></a>                <span class="at">priors=</span>spline.priors)</span></code></pre></div>
<div class="sourceCode" id="cb11"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb11-1"><a href="#cb11-1" tabindex="-1"></a><span class="co"># Predict and plot time-course relative effect</span></span>
<span id="cb11-2"><a href="#cb11-2" tabindex="-1"></a>pred <span class="ot">&lt;-</span> <span class="fu">predict</span>(mbnma)</span>
<span id="cb11-3"><a href="#cb11-3" tabindex="-1"></a><span class="co">#&gt; Priors required for: mu.1, mu.2, mu.3, mu.4</span></span>
<span id="cb11-4"><a href="#cb11-4" tabindex="-1"></a><span class="co">#&gt; Success: Elements in prior match consistency time-course treatment effect parameters</span></span>
<span id="cb11-5"><a href="#cb11-5" tabindex="-1"></a><span class="fu">plot</span>(pred)</span>
<span id="cb11-6"><a href="#cb11-6" tabindex="-1"></a><span class="co">#&gt; Reference treatment in plots is Placebo</span></span></code></pre></div>
<p><img role="img" src="data:image/png;base64,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" /><!-- --></p>
<p>As can be seen from the predicted time-course, using informative
priors for Aclidinium in this way allows us to predict itâs efficacy at
longer-term follow-up than the data alone can inform.</p>
</div>
<div id="pd-effective-number-of-parameters" class="section level4">
<h4>pD (effective number of parameters)</h4>
<p>The default value for <code>pD</code> in <code>mb.run()</code> is
<code>pD=FALSE</code>, which uses the rapid approach automatically
calculated in the <code>R2jags</code> package as
<code>pD = var(deviance)/2</code>. Whilst this is easy to calculate, it
is only an approximation to the effective number of parameters, and may
be numerically unstable <span class="citation">(Gelman et al.
2003)</span>. However, it has been shown to be reliable for model
comparison in time-course MBNMA models in a simulation study <span class="citation">(Pedder et al. 2020)</span>.</p>
<p>A more reliable method for estimating <code>pD</code> is
<code>pD=TRUE</code>, which uses the Kullback-Leibler divergence <span class="citation">(Plummer 2008)</span>. This is more reliable than the
default method used in <code>R2jags</code> for calculating the effective
number of parameters from non-linear models. The disadvantage of this
approach is that it requires running additional MCMC iterations, so can
be slightly slower to calculate.</p>
<p>A commonly-used approach in Bayesian models for calculating pD is the
plug-in method <span class="citation">(Spiegelhalter et al.
2002)</span>. However, this can sometimes result in negative
non-sensical values due to skewed posterior distributions for deviance
contributions that can arise when fitting non-linear models. As such,
this is no longer implemented within the package.</p>
</div>
<div id="correlation-between-time-course-parameters" class="section level4">
<h4>Correlation between time-course parameters</h4>
<p>Since MBNMAtime version 0.2.2, <code>mb.run()</code> no longer
automatically models correlation between time-course parameters modeled
using relative effects.</p>
<p>However, this can be enabled by setting <code>corparam=TRUE</code>).
Time-course parameters are typically correlated and this allows
information on each parameter to help inform the other(s). The
correlation is modeled using a multivariate normal distribution whose
covariance matrix <span class="math inline">\(\Sigma_t\)</span> is
modelled using a correlation defined by the parameter
<code>rhoparam</code>. In previous versions, an inverse Wishart prior
was used, though this has since been considered to overly constrain the
model.</p>
</div>
<div id="arguments-to-be-sent-to-jags" class="section level4">
<h4>Arguments to be sent to JAGS</h4>
<p>In addition to the arguments specific to <code>mb.run()</code> it is
also possible to use any arguments to be sent to
<code>R2jags::jags()</code>. Most of these relate to improving the
performance of MCMC simulations in JAGS. Some of the key arguments that
may be of interest are:</p>
<ul>
<li><code>n.chains</code> The number of Markov chains to run (default is
3)</li>
<li><code>n.iter</code> The total number of iterations per MCMC
chain</li>
<li><code>n.burnin</code> The number of iterations that are discarded to
ensure iterations are only saved once chains have converged</li>
<li><code>n.thin</code> The thinning rate which ensures that results are
only saved for 1 in every <code>n.thin</code> iterations per chain. This
can be increased to reduce autocorrelation in MCMC samples</li>
</ul>
</div>
</div>
</div>
<div id="model-selection" class="section level2">
<h2>Model Selection</h2>
<p>Detailed description of model selection based on statistical measures
such as Deviance Information Criterion (DIC) and residual deviance is
outside the scope of this vignette. However, the following approach for
model identification and selection is recommended in Pedder et al. <span class="citation">(2020)</span>, which also gives details on model fit
statistics used for comparison:</p>
<ol style="list-style-type: decimal">
<li>Identify candidate time-course functions based on observed data and
clinical/biological reasoning</li>
<li>Compare candidate time-course functions fitted with common relative
treatment effects on all time-course parameters</li>
<li>If no candidate time-course functions converge successfully,
absolute effects can be modeled on parameters for which convergence is
problematic</li>
<li>Compare selected common effects model to model(s) with random
effects on different time-course parameters</li>
<li>Compare model fitted with a univariate likelihood to one fitted with
a multivariate likelihood</li>
</ol>
<p>Finally the validity of the consistency assumption should be explored
in the selected final model (see [Consistency Testing]).</p>
</div>
<div id="mcmc-convergence" class="section level2">
<h2>MCMC Convergence</h2>
<p><code>MBNMAtime</code> runs Bayesian models in JAGS, which uses
Markov Chain Monte Carlo (MCMC) simulation <span class="citation">(JAGS
Computer Program 2017)</span>. However, the validity of results is
reliant on the MCMC chains having converged successfully on the
posterior densities of all parameters in the model. For highly
parameterised models run on relatively limited data, as is often the
case with MBNMA models, convergence can often be an challenge. Note that
convergence is <em>necessary</em> to be able to compare models and
evaluate model fit. However, successful convergence <em>does not</em>
imply good model fit.</p>
<p>A full explanation of how to facilitate and to check for convergence
is outside the scope of this vignette, but below are some simple steps
for checking convergence. None of these steps alone ensures convergence
has been successful, but interpretation of them jointly can provide
strong evidence of it.</p>
<ul>
<li>Rhat values close to 1 (&lt;1.1 is considered acceptable by some).
These are shown for monitored parameters in the summary statistics table
when an <code>&quot;mbnma&quot;</code> or <code>&quot;nma&quot;</code> object is
printed.</li>
<li>Trace plots that have a âfuzzy caterpillarâ look that shows good
mixing of MCMC chains</li>
<li>Density plots that show a smooth posterior distribution that is
similar across all chains</li>
<li>Autocorrelation plots that show low autocorrelation between
neighbouring MCMC iterations (i.e.Â low correlation at higher lags)</li>
</ul>
<p>An HTML document with all the above convergence plots can easily be
generated for all parameters in the model simultaneously using
<code>mcmcplots::mcmcplot()</code>.</p>
<p>Two steps may improve convergence when using <code>MBNMAtime</code>.
One step is to run models for more iterations (this can be done using
the <code>n.iter</code> argument in <code>mb.run()</code>). It can take
time for MCMC chains to converge, particularly for non-linear models
with limited data. It is important to note that chains should only be
monitored <em>after</em> they have converged - increasing the number of
burn-in iterations ensures that this is the case (using the
<code>n.burnin</code> argument in <code>mb.run()</code>). Another method
to improve convergence is by providing more information to the model via
informative priors.</p>
<p>For a detailed review of MCMC convergence assessment see Sinharay
<span class="citation">(2003)</span>.</p>
</div>
<div id="references" class="section level2 unnumbered">
<h2 class="unnumbered">References</h2>
<div id="refs" class="references csl-bib-body hanging-indent" entry-spacing="0">
<div id="ref-GMD2" class="csl-entry">
Daly, C., N. J. Welton, S. Dias, S. Anwer, and A. E. Ades. 2021.
<span>âNICE Guideline Methodology Document 2: Meta-Analysis of
Continuous Outcomes.â</span> Population Health Sciences, University of
Bristol; Centre for Reviews; Dissemination; Centre for Health Economics,
University of York. <a href="https://www.bristol.ac.uk/media-library/sites/social-community-medicine/documents/mpes/gmd-2-continuous-jan2021.pdf">https://www.bristol.ac.uk/media-library/sites/social-community-medicine/documents/mpes/gmd-2-continuous-jan2021.pdf</a>.
</div>
<div id="ref-dias2016" class="csl-entry">
Dias, S., and A. E. Ades. 2016. <span>âAbsolute or Relative Effects?
Arm-Based Synthesis of Trial Data.â</span> Journal Article. <em>Res
Synth Methods</em> 7 (1): 23â28. <a href="https://doi.org/10.1002/jrsm.1184">https://doi.org/10.1002/jrsm.1184</a>.
</div>
<div id="ref-friedrich2011" class="csl-entry">
Friedrich, J. O., N. K. J. Adhikari, and J. Beyene. 2011. <span>âRatio
of Means for Analyzing Continuous Outcomes in Meta-Analysis Performed as
Well as Mean Difference Methods.â</span> Journal Article. <em>Journal of
Clinical Epidemiology</em> 64 (5): 556â64. <a href="https://doi.org/10.1016/j.jclinepi.2010.09.016">https://doi.org/10.1016/j.jclinepi.2010.09.016</a>.
</div>
<div id="ref-gelman2003" class="csl-entry">
Gelman, A., J. B. Carlin, H. S. Stern, and D. B. Rubin. 2003.
<em>Bayesian Data Analysis</em>. Book. 2nd ed. CRC Press.
</div>
<div id="ref-hong2016" class="csl-entry">
Hong, H., H. Chu, J. Zhang, and B. P. Carlin. 2016. <span>âA Bayesian
Missing Data Framework for Generalized Multiple Outcome Mixed Treatment
Comparisons.â</span> Journal Article. <em>Res Synth Methods</em> 7 (1):
6â22. <a href="https://doi.org/10.1002/jrsm.1153">https://doi.org/10.1002/jrsm.1153</a>.
</div>
<div id="ref-jags" class="csl-entry">
JAGS Computer Program. 2017. <a href="https://mcmc-jags.sourceforge.io/">https://mcmc-jags.sourceforge.io/</a>.
</div>
<div id="ref-jansen2015" class="csl-entry">
Jansen, J. P., M. C. Vieira, and S. Cope. 2015. <span>âNetwork
Meta-Analysis of Longitudinal Data Using Fractional Polynomials.â</span>
Journal Article. <em>Stat Med</em> 34 (15): 2294â2311. <a href="https://doi.org/10.1002/sim.6492">https://doi.org/10.1002/sim.6492</a>.
</div>
<div id="ref-karahalios2017" class="csl-entry">
Karahalios, A. E., G. Salanti, S. L. Turner, G. P. Herbison, I. R.
White, A. A. Veroniki, A. Nikolakopoulou, and J. E. McKenzie. 2017.
<span>âAn Investigation of the Impact of Using Different Methods for
Network Meta-Analysis: A Protocol for an Empirical Evaluation.â</span>
Journal Article. <em>Syst Rev</em> 6 (1): 119. <a href="https://doi.org/10.1186/s13643-017-0511-x">https://doi.org/10.1186/s13643-017-0511-x</a>.
</div>
<div id="ref-covstruct" class="csl-entry">
Kincaid, Chuck. 2005. <span>âGuidelines for Selecting the Covariance
Structure in Mixed Model Analysis.â</span> Paper 198-30. COMSYS
Information Technology Services. <a href="https://support.sas.com/resources/papers/proceedings/proceedings/sugi30/198-30.pdf">https://support.sas.com/resources/papers/proceedings/proceedings/sugi30/198-30.pdf</a>.
</div>
<div id="ref-lu2004" class="csl-entry">
Lu, G., and A. E. Ades. 2004. <span>âCombination of Direct and Indirect
Evidence in Mixed Treatment Comparisons.â</span> Journal Article.
<em>Stat Med</em> 23 (20): 3105â24. <a href="https://doi.org/10.1002/sim.1875">https://doi.org/10.1002/sim.1875</a>.
</div>
<div id="ref-pedder2020" class="csl-entry">
Pedder, H., M. Boucher, S. Dias, M. Bennetts, and N. J. Welton. 2020.
<span>âPerformance of Model-Based Network Meta-Analysis (MBNMA) of
Time-Course Relationships: A Simulation Study.â</span> Journal Article.
<em>Research Synthesis Methods</em> 11 (5): 678â97. <a href="https://doi.org/10.1002/jrsm.1432">https://doi.org/10.1002/jrsm.1432</a>.
</div>
<div id="ref-plummer2008" class="csl-entry">
Plummer, M. 2008. <span>âPenalized Loss Functions for Bayesian Model
Comparison.â</span> Journal Article. <em>Biostatistics</em> 9 (3):
523â39. <a href="https://pubmed.ncbi.nlm.nih.gov/18209015/">https://pubmed.ncbi.nlm.nih.gov/18209015/</a>.
</div>
<div id="ref-jagsmanual" class="csl-entry">
âââ. 2017. <em>JAGS User Manual</em>. Version 4.3.0. <a href="https://people.stat.sc.edu/hansont/stat740/jags_user_manual.pdf">https://people.stat.sc.edu/hansont/stat740/jags_user_manual.pdf</a>.
</div>
<div id="ref-sinharay" class="csl-entry">
Sinharay, S. 2003. <span>âAssessing Convergence of the Markov Chain
Monte Carlo Algorithms: A Review.â</span> RR-03-07. ETS Research Report
Series.
</div>
<div id="ref-spiegelhalter2002" class="csl-entry">
Spiegelhalter, D. J., N. G. Best, B. P. Carlin, and A. van der Linde.
2002. <span>âBayesian Measures of Model Complexity and Fit.â</span>
Journal Article. <em>J R Statistic Soc B</em> 64 (4): 583â639.
</div>
</div>
</div>



<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
